Login / Signup

Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State.

Tina S IpeBlessing UgwumbaHorace J SpencerTuan LeTerry RidenourJohn ArmitageStefanie RyanShanna PearsonAtul KothariNaveen PatilRyan DareJuan C R CrescencioAnand VenkataJennifer LaudadioKhalid MohammadNaznin JamalJohn ThompsonHailey McNewMcKenzie GibbsSteve HenniganStan KellarKeith ReitzelBrandon E WalserAmanda NovakBrian Quinn
Published in: Laboratory medicine (2022)
The provision of 2 units of CCP was associated with a reduction in mortality in patients treated with high titer units within 3 days of COVID-19 diagnosis. Given the results, CCP is a viable, low-cost therapy in resource-constrained states and countries.
Keyphrases
  • low cost
  • sars cov
  • cardiovascular events
  • palliative care
  • risk factors
  • cardiovascular disease
  • type diabetes
  • stem cells
  • coronary artery disease